SCHEMBL10330428

SCHEMBL10330428

COc1ccc(C2=C(CO)S(=O)(=O)c3ccccc3C2=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ TP53 P04637 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ TSHR P16473 1/20 0.50
▸ HSP90AA1 P07900 6/20 0.48
▸ MEN1 O00255 5/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ HTT P42858 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ MPI P34949 1/20 0.48
▸ HKDC1 Q2TB90 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ HSP90AB1 P08238 5/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10330434 0.89 CHEK1 (0.45) MAPTNPC1TP53RAB9ASMN1; SMN2
SCHEMBL10330427 0.85 CHEK1 (0.50) MAPTSMN1; SMN2HSP90AA1MEN1KMT2A
SCHEMBL10330432 0.81 CHEK1 (0.47) MAPTSMN1; SMN2TSHRMEN1KMT2A
SCHEMBL10330429 0.73 CHEK1 (0.45) RAB9ASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL19821674 0.72 HSP90AA1 (0.45) MAPTNPC1TP53RAB9ASMN1; SMN2
SCHEMBL19821675 0.72 HSP90AA1 (0.43) MAPTTSHRHSP90AA1MEN1KMT2A
SCHEMBL19827143 0.71 CHEK1 (0.42) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL14773924 0.70 ME2 (0.74) MAPTNPC1TP53RAB9ASMN1; SMN2
SCHEMBL19827140 0.69 MEN1 (0.42) MAPTSMN1; SMN2TSHRHSP90AA1MEN1
SCHEMBL10330395 0.69 ALDH1A1 (0.42) MAPTSMN1; SMN2TSHRHSP90AA1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222429-B2 Photodissociable protective group National University Corporation NARA Institute of Science and Technology (JP) 2012-07-17 — — US disclosed
US-8222429-B2 Photodissociable protective group National University Corporation NARA Institute of Science and Technology (JP) 2012-07-17 — — US disclosed
US-20110028738-A1 PHOTODISSOCIABLE PROTECTIVE GROUP National University Corporation NARA Institute of Science and Technology (JP) 2011-02-03 — — US disclosed
US-20110028738-A1 PHOTODISSOCIABLE PROTECTIVE GROUP National University Corporation NARA Institute of Science and Technology (JP) 2011-02-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028738-A1 PHOTODISSOCIABLE PROTECTIVE GROUP CRY2, CRY1, APEX1 MAPT 4249/4885NPC1 4455/4885TP53 4246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback